CY1218A - Pyridopyrimidines - Google Patents

Pyridopyrimidines

Info

Publication number
CY1218A
CY1218A CY1218A CY121878A CY1218A CY 1218 A CY1218 A CY 1218A CY 1218 A CY1218 A CY 1218A CY 121878 A CY121878 A CY 121878A CY 1218 A CY1218 A CY 1218A
Authority
CY
Cyprus
Prior art keywords
pyridopyrimidines
Prior art date
Application number
CY1218A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CY1218A publication Critical patent/CY1218A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
CY1218A 1977-05-25 1978-05-24 Pyridopyrimidines CY1218A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/800,264 US4122274A (en) 1977-05-25 1977-05-25 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Publications (1)

Publication Number Publication Date
CY1218A true CY1218A (en) 1984-04-06

Family

ID=25177928

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1218A CY1218A (en) 1977-05-25 1978-05-24 Pyridopyrimidines

Country Status (26)

Country Link
US (1) US4122274A (fr)
JP (1) JPS6050197B2 (fr)
AT (1) AT365187B (fr)
AU (1) AU521211B2 (fr)
BE (1) BE867295A (fr)
CA (1) CA1098520A (fr)
CH (1) CH642656A5 (fr)
CY (1) CY1218A (fr)
DE (1) DE2822544A1 (fr)
DK (1) DK160279C (fr)
FI (1) FI64594C (fr)
FR (1) FR2401159A1 (fr)
GB (1) GB1596476A (fr)
GR (1) GR71887B (fr)
HK (1) HK25884A (fr)
IE (1) IE46849B1 (fr)
IT (1) IT1105040B (fr)
KE (1) KE3357A (fr)
LU (1) LU79694A1 (fr)
MY (1) MY8500305A (fr)
NL (1) NL190702C (fr)
NO (1) NO150361C (fr)
SE (1) SE437830B (fr)
SG (1) SG73383G (fr)
YU (2) YU42163B (fr)
ZA (1) ZA782816B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
DK169580B1 (da) * 1985-09-25 1994-12-12 Shionogi & Co 9-(substitueret thio)-4H-pyrido[1,2-a]pyrimidin-4-on-derivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende sådanne derivater
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
JPS62242682A (ja) * 1986-04-16 1987-10-23 Tokyo Tanabe Co Ltd 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
US5034230A (en) * 1987-12-25 1991-07-23 Santen Pharmaceutical Co., Ltd. Anti-allergic ophthalmics
CA2010336C (fr) * 1989-02-27 1996-11-19 Atsunori Sano Procede de production d'un derive de pyrido [1,2-a] pyrimidine
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
US5525605A (en) 1992-07-30 1996-06-11 Tokyo Tanabe Company Limited Remedy for inflammatory intestinal diseases
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
JPH0892093A (ja) * 1994-11-10 1996-04-09 Tokyo Tanabe Co Ltd ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤
KR100885007B1 (ko) * 2001-02-26 2009-02-20 미쓰비시 타나베 파마 코퍼레이션 신질환·신부전의 예방 또는 치료를 위한 약학 조성물
ITMI20011764A1 (it) * 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
KR20090106526A (ko) * 2006-12-18 2009-10-09 카르도스 아베 염증 질환 치료를 위한 새로운 조합
ES2395120T3 (es) * 2006-12-20 2013-02-08 Cardoz Ab Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios
AU2008273997A1 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a PPAR gamma agonist
WO2009007679A2 (fr) * 2007-07-11 2009-01-15 Cardoz Ab Nouvelle association pour une utilisation dans le traitement de troubles inflammatoires
WO2009007675A2 (fr) * 2007-07-11 2009-01-15 Cardoz Ab Nouvelle association pour une utilisation dans le traitement de troubles inflammatoires
CA2720547A1 (fr) * 2008-04-07 2009-10-15 Cardoz Ab Nouvelle combinaison pour une utilisation dans le traitement de troubles inflammatoires
SI2443120T1 (sl) 2009-06-16 2017-04-26 Rspr Pharma Ab Kristalna oblika pemirolasta
USD661900S1 (en) 2010-02-22 2012-06-19 Bajer Design & Marketing, Inc. Collapsible structure
MX354074B (es) 2012-02-10 2018-02-12 Ptc Therapeutics Inc Compuestos para tratar la atrofia muscular espinal.
BR112014021531B1 (pt) 2012-03-01 2022-10-04 Ptc Therapeutics, Inc. Composto, composição farmacêutica e usos dos mesmos
US9914722B2 (en) 2012-03-23 2018-03-13 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EP3082820B1 (fr) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Procédés pour moduler la quantité de transcrits d'arn
WO2016063085A1 (fr) 2014-10-23 2016-04-28 Rspr Pharma Ab Utilisation de pemirolast dans le traitement de l'asthme aigu
WO2016102941A1 (fr) 2014-12-22 2016-06-30 Rspr Pharma Ab Nouvelle association pémirolast et montélukast
WO2016184832A1 (fr) * 2015-05-20 2016-11-24 F. Hoffmann-La Roche Ag Composés pour le traitement d'une amyotrophie spinale
WO2016196386A1 (fr) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Procédés de modulation de l'épissage de l'arn
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
ES2879995T3 (es) 2015-12-10 2021-11-23 Ptc Therapeutics Inc Métodos para el tratamiento de la enfermedad de Huntington
GB201601138D0 (en) * 2016-01-21 2016-03-09 Rspr Pharma Ab New use
US11702646B2 (en) 2016-11-28 2023-07-18 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
EA201992878A1 (ru) 2017-06-05 2020-05-08 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни хантингтона
CN111372611A (zh) 2017-06-14 2020-07-03 Ptc医疗公司 修饰rna剪接的方法
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
EP3814360A1 (fr) 2018-06-27 2021-05-05 PTC Therapeutics, Inc. Composés hétéroaryles pour le traitement de la maladie de huntington

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT302311B (de) * 1966-11-02 1972-09-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung von homopyrimidazol-derivaten und deren saeureadditionssalzen und quaternaeren ammoniumsalzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones

Also Published As

Publication number Publication date
BE867295A (fr) 1978-11-20
FI781614A (fi) 1978-11-26
FI64594B (fi) 1983-08-31
SG73383G (en) 1984-08-03
NL190702C (nl) 1994-07-01
YU44212B (en) 1990-04-30
IT7849523A0 (it) 1978-05-24
DK160279C (da) 1991-07-22
MY8500305A (en) 1985-12-31
YU123678A (en) 1983-02-28
NO781786L (no) 1978-11-28
JPS5436294A (en) 1979-03-16
LU79694A1 (fr) 1979-02-02
AU521211B2 (en) 1982-03-25
AT365187B (de) 1981-12-28
FR2401159A1 (fr) 1979-03-23
DE2822544C2 (fr) 1988-10-27
NO150361B (no) 1984-06-25
CH642656A5 (de) 1984-04-30
FI64594C (fi) 1983-12-12
YU233082A (en) 1988-08-31
DK160279B (da) 1991-02-18
IE781036L (en) 1978-11-25
NL190702B (nl) 1994-02-01
AU3631978A (en) 1979-11-29
SE7805954L (sv) 1978-11-26
ATA373278A (de) 1981-05-15
ZA782816B (en) 1979-05-30
JPS6050197B2 (ja) 1985-11-07
IE46849B1 (en) 1983-10-05
GR71887B (fr) 1983-08-04
NO150361C (no) 1984-10-03
US4122274A (en) 1978-10-24
DE2822544A1 (de) 1978-12-07
CA1098520A (fr) 1981-03-31
DK228878A (da) 1978-11-26
HK25884A (en) 1984-03-30
GB1596476A (en) 1981-08-26
SE437830B (sv) 1985-03-18
FR2401159B1 (fr) 1983-05-20
IT1105040B (it) 1985-10-28
KE3357A (en) 1984-02-03
NL7805534A (nl) 1978-11-28
YU42163B (en) 1988-06-30

Similar Documents

Publication Publication Date Title
MY8500305A (en) Pyridopyrimidines
GB2010944A (en) Sound-absorbingstructures
NZ187543A (en) 1-acetylenealkylamines
AU3728978A (en) Sulfamoyl-aryl-ketones
MY8500946A (en) 3-indolyl-tertiary butylaminopropanols
AU4022878A (en) Thiopropionamides
GB2031894B (en) 6-deoxy-5-oxoneamines
JPS5416423A (en) Alphaafluoromethyllalphaaaminoalkanoate
AU3677378A (en) N-acylmethyl-chloroacetanilides
AU3828478A (en) Benzodiazepine-diones
ZA787156B (en) 4a-aryl-octahydro-1h-2-pyrindines
AU3785078A (en) Piperidino-propanols
KE3501A (en) Dibenzocycloheptenimines
JPS546386A (en) Hemodynamometer
AU3918778A (en) Beta-substituted-diketones
AU3939078A (en) 2-chlorosulfinylazetidin-4-ones
GB2009145A (en) Didehydro-prostaglandins
AU4026278A (en) Thienobenzazepines
AU3355078A (en) Aryl-hexafuranosides
AU3939978A (en) 2-guanidinomethyl-indoline
AU3533578A (en) Micro-mill-mixer
AU3774978A (en) Butyl-p-benzoylbenzoates
GB2043625B (en) Forphenicinol
AU3845478A (en) Isoquinoline-diones
GB2001693A (en) Door-catch